Industry: Biomedical Region: Spain Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A biopharmaceutical company in Spain, focusing on oncology. Committed to drawing inspiration from the ocean and discovering molecules with anti-tumor activity, it has a large marine biological library with more than 350,000 samples. The company is committed to developing innovative products and providing new tools for medical staff to treat cancer. The company's commitment to patients and research has made it one of the leading enterprises in the discovery of marine anti-tumor drugs, with candidate drug production lines and strong tumor research and development plans. The company has subsidiaries in Germany, Italy, France, Switzerland, Belgium, Austria and the United States, and also wholly owns other companies: a molecular diagnosis company; A therapeutic application company dedicated to the study of gene silencing (RNAi).
Drug development process:
Discovery of new creatures in ocean exploration
Screening anticancer properties
The anticancer compounds in the sample were separated by fractionation.
In vitro and in vivo testing
Application field:
Treating soft tissue sarcoma and ovarian cancer
Treating small cell lung cancer
Treat multiple myeloma